Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
Related Questions
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
How do you decide on treatment modality for ocular surface squamous neoplasia?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
How do you manage corneal ectasia after refractive surgery?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
What factors influence your decision to pursue surgical management in cases of infectious keratitis caused by multidrug-resistant pathogens?
When do you consider performing laser refractive surgery on corneal transplants?
Is there any benefit from oral vs topical steroids in herpes zoster opthalmicus?
